Physician profile
Katelyn Klosterman
NPI 1003312422
$747.58
in general payments reported to CMS, 2019-2025
12 companies · $302 in 2025
The $302 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $15.63 · 2023: $199 · 2024: $231 · 2025: $302.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $732.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $731.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $191.28 | 2023-2025 | Mounjaro, Zepbound, Trulicity |
| Novo Nordisk INC | $159.27 | 2023-2025 | Ozempic, Rybelsus, Wegovy |
| Amgen INC. | $67.34 | 2024-2025 | Evenity, Prolia |
| Exact Sciences Corporation | $60.43 | 2024-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Glaxosmithkline, LLC. | $59.70 | 2022-2024 | Bexsero, Shingrix, Arexvy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $58.45 | 2023-2025 | Jardiance |
| Pfizer INC. | $47.58 | 2023-2025 | |
| Impactortho, INC. | $32.20 | 2025 | |
| Xeris Pharmaceuticals, INC. | $19.16 | 2024 | Recorlev |
| Inspire Medical Systems, INC. | $18.64 | 2024 | Inspire |
| Janssen Pharmaceuticals, INC | $17.73 | 2025 | Spravato |
| Radius Health, INC. | $15.80 | 2024 | Tymlos |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Katelyn Klosterman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.